Skip to content
Review

Strengthening muscle for healthy ageing: innovative treatments for sarcopenia.

Sep 2026 · Nature reviews. Drug discovery · 0 citations · 267 references
Medicine

TL;DR

The recent surge in clinical trials combining weight loss-inducing GLP1RA therapies with drugs that preserve muscle tissue suggests that treatments that promote both healthspan and lifespan, or 'healthy ageing', are on the horizon.

View source

Similar papers

Review Sep 2026

The triad of muscle health: gut–muscle axis in the context of sarcopenia and exercise, a narrative review

Key mechanistic evidence demonstrating how targeted GM interventions and structured exercise regimens may synergistically counteract muscle decline is explored, to support the development of innovative therapeutic approaches combining exercise and GM modulation to improve muscle health, functional independence, and hea...

Ana Sofia Merelim, Ângelo P. Santos, Rodrigo Zacca et al. · 0 citations
Review Open access Oct 2026

Are we at risk of increasing sarcopenia? Implications for osteoarthritis and osteoporosis.

Sarcopenia is a progressive skeletal muscle disorder characterised by reduced muscle strength, impaired muscle quantity or quality, and declining physical performance, with important consequences for falls, fractures, disability, and loss of independence. Whether sarcopenia prevalence itself is rising remains difficult...

F. Pan, F. Cicuttini · 0 citations
Review Open access Aug 2026

Sarcopenia as a Disorder of Skeletal Muscle Homeostasis: A Five-Pillar Translational Framework Linking Mechanisms, Diagnosis, and Treatment

Sarcopenia is a progressive skeletal muscle disorder in which clinically relevant muscle failure is expressed primarily as reduced muscle strength, with low muscle quantity or quality used to confirm the diagnosis and impaired physical performance indicating greater severity in the EWGSOP2 (European Working Group on Sa...

E. Główczewska-Siedlecka, M. Szafrańska, Agata Doligalska-Dolina et al. · 0 citations
Review Open access Sep 2026

Aging of Skeletal Muscle: From Molecular Mechanisms to Therapeutic Interventions

Skeletal muscle aging is a major cause of frailty, metabolic dysfunction, and loss of independence in later life, yet it cannot be explained by muscle mass loss alone. Recent single‐cell, multi‐omics, and translational studies show that aged muscle is shaped by coordinated changes in myofibers, stem and stromal cells,...

Ting Liu, Yao-Min Hu · 0 citations
Review Open access Aug 2026

Reframing sarcopenia as a disease of the ageing motor system.

Sarcopenia is a major driver of disability, frailty, and loss of independence in ageing populations. Current consensus definitions have shifted from low muscle mass to low muscle strength and impaired physical performance as the defining clinical features. The underlying disease model, however, has remained predominant...

L. B. R. Orssatto, W. D. Arnold, L. Ferrucci et al. · 1 citation
Review Open access Sep 2026

Sarcopenia as a manifestation of systemic energetic failure with ageing.

Sarcopenia remains underdiagnosed and undertreated, partly because it continues to be mainly conceptualised as a disorder intrinsic to skeletal muscle. Although current definitions incorporate muscle strength and physical performance, they are not intended to explain the integrated physiological processes that underlie...

Luigi Ferrucci, S. Donegà, A. Picca et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.